Charles River Labs Intl buy Bank of America Co.
Start price
15.12.25
/
50%
€168.60
Target price
15.12.26
€191.66
Performance (%)
-9.52%
Price
09.03.26
€152.55
Summary
This prediction is currently active. With a performance of -9.52%, the BUY prediction for Charles River Labs Intl by Bank_of_America_Co_ is down slightly. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | -1.134% | -1.134% |
| iShares Core DAX® | -2.526% | -5.194% |
| iShares Nasdaq 100 | -0.032% | 1.561% |
| iShares Nikkei 225® | -4.202% | -7.550% |
| iShares S&P 500 | -0.802% | 0.160% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat